ARVNInvestorglobenewswire

Arvinas to Participate in Upcoming Investor Conferences

Sentiment:Negative (15)

Summary

(NASDAQ:ARVN) NEW HAVEN, Conn., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will participate in fireside chats at two upcoming investor conferences:

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 29, 2025 by globenewswire

    Arvinas to Participate in Upcoming Investor Conferences | ARVN Stock News | Candlesense